Related Experiment Videos
Baroreflex responsiveness in borderline hypertensives: a study with neostigmine
Cardiovascular Research
|August 1, 1981
Summary
Baroreflex sensitivity is reduced in borderline and established hypertension. Neostigmine improved baroreflex responses in borderline hypertensives, suggesting reduced parasympathetic activity contributes to altered baroreflex sensitivity.
Area of Science:
- Cardiovascular Physiology
- Hypertension Research
Background:
- Baroreflex dysfunction is implicated in hypertension.
- Understanding baroreflex alterations in borderline hypertension is crucial for early intervention.
Purpose of the Study:
- To evaluate baroreflex sensitivity in borderline hypertensives compared to normal and established hypertensive subjects.
- To investigate the role of parasympathetic activity in borderline hypertensive baroreflex dysfunction.
Main Methods:
- Assessed baroreceptor sensitivity using phenylephrine-induced blood pressure increase and neck chamber-induced pressure changes.
- Measured heart rate and blood pressure responses to stimuli.
- Administered neostigmine to borderline hypertensives to assess its effect on baroreflex responses.
Main Results:
- Both borderline and established hypertensives exhibited depressed heart rate responses to phenylephrine compared to controls.
- Hypertensive groups showed blunted heart rate and pressor responses to increased neck tissue pressure.
- Neostigmine administration improved baroreflex responses in borderline, but not established, hypertensives.
Conclusions:
- Reduced parasympathetic activity is a contributing factor to impaired baroreflex sensitivity in borderline hypertension.
- Baroreflex dysfunction is present early in the hypertensive process.